DNA fragmentation

Jack Chu Joins Legacy as Vice President of Technology

Retrieved on: 
Thursday, January 18, 2024
Patient, Health, Away, Male, STI, Freezing, Harvard University, Safety, Modern era, Laboratory, DNA fragmentation, Growth

NEW YORK, Jan. 18, 2024 /PRNewswire/ -- Legacy, the leading sperm company in the United States, welcomes Jack Chu as the new Vice President of Technology to create robust, scalable systems as the company continues to grow. Chu's extensive experience in technology leadership paired with his proven track record of driving innovation within high-growth companies, positions him as a key player in Legacy's ongoing commitment to technological advancement and continuous innovation.

Key Points: 
  • "Legacy's pioneering approach, offering at-home sperm testing and preservation, resonates with my belief that technology can greatly advance health care accessibility."
  • Before joining Legacy, Chu served as the Chief Technology Officer at Modern Age, a healthtech company dedicated to improving global life expectancy.
  • "We are delighted to have Jack Chu as our Vice President of Technology.
  • As Vice President of Technology, Chu will oversee Legacy's technology initiatives, driving the development and implementation of advanced solutions to enhance the overall user experience.

PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform

Retrieved on: 
Monday, December 4, 2023
Manufacturing, Other Health, Environment, Other Science, Pharmaceutical, Research, Other Technology, Sustainability, Medical Devices, Hardware, Science, Technology, Medical Supplies, General Health, Agriculture, Natural Resources, Health, Health Technology, Chemicals, Plastics, Massive parallel sequencing, Safety, DNA, Laboratory, Food, Genomics, Medicine, Data analysis, PerkinElmer, DNA fragmentation, Drug discovery, Growth, NGS, Fine chemical, Renewable energy, Eddy covariance

The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market.

Key Points: 
  • The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market.
  • Covaris’ solutions empower customers to accelerate the pace of research and drug discovery for clinical diagnostics, biopharma, and research markets globally.
  • We see significant growth opportunities resulting from the combined resources of both companies, with PerkinElmer’s global scale unlocking commercial opportunities for Covaris,” said Dirk Bontridder, CEO of PerkinElmer.
  • Covaris will now have access to PerkinElmer’s global reach, technical and operating capabilities to continue its rapid growth trajectory.

Rebecca Silver Joins Legacy as Head of Marketing

Retrieved on: 
Tuesday, October 31, 2023
Fertility, DNA fragmentation, Silver, Ancestry.com, Growth, Patient, Freezing, Health, Head, STI, Birth control, Legacy, Marketing

NEW YORK, Oct. 31, 2023 /PRNewswire/ -- Legacy, America's largest at-home fertility clinic for people with sperm, appoints Rebecca Silver as their new Head of Marketing. Silver's extensive background in the fertility space coupled with her proven track record of leading successful marketing functions at high growth companies makes her a critical component in Legacy's next phase of growth.

Key Points: 
  • NEW YORK, Oct. 31, 2023 /PRNewswire/ -- Legacy, America's largest at-home fertility clinic for people with sperm, appoints Rebecca Silver as their new Head of Marketing.
  • Before joining Legacy, Silver oversaw marketing at LetsGetChecked, a prominent virtual care company offering at-home health testing.
  • Prior to that, she led marketing at women's health and fertility company Kindbody, where she was also a founding member.
  • As Head of Marketing, Silver will oversee the marketing and design teams while driving overarching company strategy to achieve revenue and commercialization goals.

Legacy Appoints Veteran COO, Steve Finnern, to propel company through next phases of growth

Retrieved on: 
Wednesday, October 25, 2023
Knowledge, Fintech, Family, DNA fragmentation, Growth, Freezing, Patient, STI, Birth control, Airline, Legacy

NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Legacy, America's largest at-home fertility clinic for people with sperm, appoints Steve Finnern as its new President & COO. Finnern brings a wealth of knowledge with 20+ years working with innovative tech companies across multiple industries and stages. Steve joins Legacy to institute a strong and scalable internal infrastructure as they continue on their path becoming the global leader in sperm testing and freezing.

Key Points: 
  • NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Legacy, America's largest at-home fertility clinic for people with sperm, appoints Steve Finnern as its new President & COO.
  • Steve joins Legacy to institute a strong and scalable internal infrastructure as they continue on their path becoming the global leader in sperm testing and freezing.
  • Through this experience, he has established himself as an impactful leader with expertise in realizing rapid growth across varied industries.
  • "It is an exciting time for the company and I am looking forward to harnessing the momentum and elevating Legacy to a common household name."

NGS Sample Preparation Market worth $4.0 billion | MarketsandMarkets

Retrieved on: 
Monday, March 6, 2023
Agilent Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company headquarters, Roche, Acquisition, Workflow, DNA, Sysmex Corporation, Data analysis, DNA fragmentation, Partnership, PPD, Illumina, Inc., Investment, QIAGEN, Automation, Promega, NGS, RNA, BGI, Growth, New England Biolabs, Merck, Data collection, Quality control, PerkinElmer, Retail, Fine chemical, Pension fund, Video game, Illumina

Based on workflow, the NGS sample preparation market is segmented into DNA fragmentation & library preparation, target enrichment, and quality control.

Key Points: 
  • Based on workflow, the NGS sample preparation market is segmented into DNA fragmentation & library preparation, target enrichment, and quality control.
  • In 2022, the DNA fragmentation &library segment accounted for the fastest-growing share of the workflow segment of NGS sample preparation market.
  • Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098
    NGS Sample Preparation Market Dynamics:
    The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market.
  • Tracking product portfolios of prominent market players helps to analyze the major types in the NGS sample preparation market.

NGS Sample Preparation Market worth $4.0 billion | MarketsandMarkets

Retrieved on: 
Monday, March 6, 2023
Agilent Technologies, Thermo Fisher Scientific, Becton, Dickinson and Company headquarters, Roche, Acquisition, Workflow, DNA, Sysmex Corporation, Data analysis, DNA fragmentation, Partnership, PPD, Illumina, Inc., Investment, QIAGEN, Automation, Promega, NGS, RNA, BGI, Growth, New England Biolabs, Merck, Data collection, Quality control, PerkinElmer, Retail, Fine chemical, Pension fund, Video game, Illumina

Based on workflow, the NGS sample preparation market is segmented into DNA fragmentation & library preparation, target enrichment, and quality control.

Key Points: 
  • Based on workflow, the NGS sample preparation market is segmented into DNA fragmentation & library preparation, target enrichment, and quality control.
  • In 2022, the DNA fragmentation &library segment accounted for the fastest-growing share of the workflow segment of NGS sample preparation market.
  • Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098
    NGS Sample Preparation Market Dynamics:
    The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market.
  • Tracking product portfolios of prominent market players helps to analyze the major types in the NGS sample preparation market.

Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health

Retrieved on: 
Tuesday, January 10, 2023
DNA fragmentation, Infertility, Artificial insemination, SALT, Reproductive health, Chromosome, Fertility, Male, Standard of care, DNA, Semen analysis, IUI, Environment, Gene, Woman, Patient, Doctor of Philosophy, Birth control

Many men go undiagnosed and when men go undiagnosed, women are put through procedures that will not work.

Key Points: 
  • Many men go undiagnosed and when men go undiagnosed, women are put through procedures that will not work.
  • Inherent and Posterity are elevating the standard of care and improving access to care for men, shifting some of the burden of infertility from women.
  • Together the companies offer a comprehensive diagnostic and treatment offering now available directly to male patients trying to conceive.
  • "Inherent Biosciences is pioneering innovation in male reproductive health," said Pam Pure, CEO of Posterity Health.

Legacy Partners With the US Department of Veterans Affairs to Analyze Fertility in Global War On Terror Veterans

Retrieved on: 
Tuesday, August 23, 2022
Research, Technology, Other Defense, Men, Telecommunications, General Health, Consumer, Health, Science, Defense, Partnership, CEO, GWOT, CRADA, Veterans benefits for post-traumatic stress disorder in the United States, VHA, FirstMark Capital, Time, Harvard Innovation Labs, Section 32, Burn, DNA fragmentation, Orlando Bloom, Veterans Health Administration, Y Combinator, Memorial Sloan Kettering Cancer Center, Manchester VA Medical Center, United States Naval Special Warfare Command, Male, DNA, War on terror, Organization, MD, Cryopreservation, Former, Fertility, Cooperative research and development agreement, Learning, STI, United States Army Special Forces, Madigan Army Medical Center, Knowledge, DJ Khaled, Infertility, Bain Capital Ventures, Health, Freezing, Development, Birth control, Hospital, Veteran, Legacy, Veterans' affairs

The study aims to shed light on the potential causes of infertility in the military.

Key Points: 
  • The study aims to shed light on the potential causes of infertility in the military.
  • Military members who have served in recent conflicts are 2X more likely to experience infertility, yet the cause of this widespread problem is greatly misunderstood.
  • With this data, the VHA will be able to expand the fertility services offered to veterans who struggle with infertility as a result of their service in the military.
  • David Shulkin, MD, Former Secretary of the US Department of Veterans Affairs noted, infertility has been largely ignored when it comes to toxic exposures.

Covaris Appoints Annemarie Watson as Chief Executive Officer

Retrieved on: 
Monday, August 1, 2022
Other Manufacturing, Research, Finance, Genetics, Professional Services, Manufacturing, Biotechnology, Health, Science, Harvard Business School, DNA, Ortho Clinical Diagnostics, Radiopharmaceutical, Laboratory, Industry, Boston Consulting Group, Culture, Research, DNA fragmentation, New Mountain, Honda, CTO, Crane Currency, Leadership, Technology, MBA, Senior, Senior advisor, Honda of Canada Manufacturing, Boston, New Mountain Capital, LLC, Eurofins Scientific, Growth, MDS, Mathematics, Mass spectrometry, Management, Eddy covariance, Engineering, Director, Nordion

Covaris, LLC (Covaris or the Company), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately.

Key Points: 
  • Covaris, LLC (Covaris or the Company), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately.
  • Ms. Watson succeeds Covaris founder Jim Laugharn, who will remain an investor in Covaris and on serve on the Companys Board of Directors, as well as assuming the role of Chief Technology Officer.
  • We look forward to working with Annemarie as we leverage Covaris leading biomolecule extraction technology to accelerate life sciences innovation.
  • I am grateful to have been given the opportunity to lead Covaris, a leader in the life sciences industry with a strong culture of innovation, said Annemarie Watson, Chief Executive Officer of Covaris.

Taiwan iPreg Inc. to exhibit the newest Sperm Supporting Chip: A New Solution for Infertility at CES 2022 Taiwan Tech Arena Pavilion

Retrieved on: 
Friday, July 29, 2022
DNA, Environment, Blastocyst, CES, Fertility clinic, Pregnancy rate, Spermatozoon, Egg, Infertility, Research, IP, Reproduction, DNA fragmentation, Reproductive medicine, Pavilion, Safety, Family, Multimedia, Pregnancy, Fertilisation, Technology, Semen, Method, Fertility, Doctor of Philosophy, IVF, Efficiency, Program, TTA, ART, Medical device, Birth control, Immunology, Vitro, Intellectual

This uniquely designed chip also increases the purity of healthy sperm to 90% while posing minimum damage to the DNA.

Key Points: 
  • This uniquely designed chip also increases the purity of healthy sperm to 90% while posing minimum damage to the DNA.
  • Sperm preparation by iPreg sorting chip increases the healthy sperm ratio to 90% in 15 minutes while maintaining the patient's safety as well as high recovery and efficiency.
  • This plays an important role in assisting reproduction that speeds up the crucial stage of sperm screening in the IVF process.
  • iPreg Incorporation will be showcasing its technology at the Taiwan Tech Arena (TTA) Pavilion at Eureka Park, Venetian Expo 1F (Former Sands expo), booth no: 61423.